Amia Capital LLP Ionis Pharmaceuticals Inc Transaction History

Amia Capital LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 11, 2021	SELL	$45.3 - $60.27 $1.93 Million - $2.56 Million	-42,552 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$47.45 - $62.95 $125,600 - $166,628	-2,647 Reduced 5.86%	42,552 $2.02 Million
Q2 2020 Aug 14, 2020	SELL	$46.85 - $61.05 $1.15 Million - $1.49 Million	-24,479 Reduced 35.13%	45,199 $2.67 Million
Q1 2020 May 15, 2020	SELL	$41.6 - $63.4 $949,894 - $1.45 Million	-22,834 Reduced 24.68%	69,678 $3.29 Million
Q4 2019 Feb 13, 2020	BUY	$53.85 - $65.27 $4.98 Million - $6.04 Million	92,512 New	92,512 $5.59 Million

402

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $4.83B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Amia Capital LLP, based on Form 13F filings with the SEC.

Stay updated on Amia Capital LLP with notifications on news.